• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,583.69 98.81
(0.18%)
Dow Jones
7,750.97 54.27
(0.71%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,795.58 -82.54
(-0.76%)
Forex
USD-INR
95.26 -0.05
(-0.05%)
EUR-INR
111.07 -0.11
(-0.10%)
GBP-INR
129.70 -0.28
(-0.21%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Curis Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
94348
INE1BZN01016
58.5748291
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CURIS
14.58
101.02
EPS(TTM)
Face Value()
Div & Yield %
8.57
10
0
 

Forbes & Company reports consolidated net loss of Rs 1.97 crore in the March 2026 quarter
May 15,2026
Net loss of Forbes & Company reported to Rs 1.97 crore in the quarter ended March 2026 as against net profit of Rs 102.84 crore during the previous quarter ended March 2025. Sales declined 80.62% to Rs 17.19 crore in the quarter ended March 2026 as against Rs 88.68 crore during the previous quarter ended March 2025.

For the full year,net profit declined 89.08% to Rs 13.41 crore in the year ended March 2026 as against Rs 122.76 crore during the previous year ended March 2025. Sales declined 61.78% to Rs 76.14 crore in the year ended March 2026 as against Rs 199.23 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17.1988.68 -81 76.14199.23 -62
OPM %-4.7113.02 -9.9813.06 -
PBDT0.4113.50 -97 21.0941.82 -50
PBT-0.8513.09 PL 18.1840.24 -55
NP-1.97102.84 PL 13.41122.76 -89